| Identification | Back Directory | [Name]
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]- | [CAS]
1263131-92-5 | [Synonyms]
MRT-83
Inhibitor,MRT-83,MRT83,Smo,MRT 83,inhibit,Smoothened
N-[amino-[4-methyl-3-[(4-phenylbenzoyl)amino]anilino]methylidene]-3,4,5-trimethoxybenzamide
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]- | [Molecular Formula]
C31H30N4O5 | [MDL Number]
MFCD25977098 | [MOL File]
1263131-92-5.mol | [Molecular Weight]
538.594 |
| Chemical Properties | Back Directory | [density ]
1.22±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
10.29±0.46(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
MRT-83 is a novel potent antagonist of SMO, which has been shown to be useful for manipulating Hh signaling and may help develop new therapies against Hh-pathway related diseases. | [in vivo]
Animals treated with ShhN in the presence of MRT-83 are as healthy as those of the other groups but up-regulation of Ptc transcription in the SVZ of these animals is no longer observed in agreement with a complete inhibition of ShhN-mediated effects (8.7±2.4 Ptc+ cells/section, n=9) and is not different from vehicle-mediated effects. MRT-83 but not MRT-36 antagonizes the up-regulation of Ptc transcription induced by ShhN in vivo in the SVZ of the LV[1]. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|